Gail F. Schwartz - Concepedia

Author

Gail F. Schwartz

Johns Hopkins University

Also Known As

G F Schwartz, G.F. Schwartz, GAIL F. SCHWARTZ, Gail F Schwartz, Gail F. Schwartz, Gail F. Schwartz,, Gail Schwartz

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Greater Baltimore Medical Center Pfizer (United States)University of Maryland, Baltimore Allergan (Ireland)

About

Gail F. Schwartz is an author at Johns Hopkins University specializing in ophthalmology, medicine, and glaucoma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	477
2	Pharmacology	3	3	49
3	Social Sciences	1	1	12
4	Rehabilitation	1	1	12
5	Drug Monitoring	1	1	15

Gail F. Schwartz

Publications

844

Citations

H-Index

Page 1

	Year	Citations
Patient persistency with topical ocular hypotensive therapy in a managed care population Gregory Reardon, Gail F. Schwartz, Essy Mozaffari American Journal of Ophthalmology Care PopulationOcular DiseaseOphthalmologyEye HealthPatient Persistency	2003	126
Persistency with latanoprost or timolol in primary open-angle glaucoma suspects Gail F. Schwartz, Gregory Reardon, Essy Mozaffari American Journal of Ophthalmology Ocular DiseaseOphthalmologyOcular PathologyGlaucomaMedicine	2003	92
Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension Gail F. Schwartz, David Hollander, Julia Williams Current Medical Research and Opinion	2013	78
Patient Persistency with ocular prostaglandin therapy: A population-based, retrospective study Gregory Reardon, Gail F. Schwartz, Essy Mozaffari Clinical Therapeutics Ocular DiseaseOphthalmologyEye HealthPharmacotherapyPatient Persistency	2003	68
Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data. Samaresh Dasgupta, Vikki Oates, Brahim Bookhart, PubMed Ocular DiseaseOphthalmologyPharmaceutical PracticePopulation-based Persistency RatesOutcomes Research	2002	67
Patient Persistency with Pharmacotherapy in the Management of Glaucoma Gregory Reardon, Gail F. Schwartz, Essy Mozaffari European Journal of Ophthalmology	2003	52
Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial Douglas G. Day, Thomas R. Walters, Gail F. Schwartz, British Journal of Ophthalmology	2013	51
Accounting for Restart Rates in Evaluating Persistence with Ocular Hypotensives Gail F. Schwartz, Robert W. Platt, Gregory Reardon, Ophthalmology Ocular DiseaseOphthalmologyExperimental OphthalmologyPhysiologyRestart Rates	2007	42
Resuturing the Scleral Flap Leads to Resolution of Hypotony Maculopathy Gail F. Schwartz, Alan L. Robin, Richard P. Wilson, Journal of Glaucoma	1996	29
Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy Gregory Reardon, Gail F. Schwartz, Sameer Kotak BMC Ophthalmology	2010	22

Page 1